250 related articles for article (PubMed ID: 27497815)
21. Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder.
Econs MJ; McEnery PT
J Clin Endocrinol Metab; 1997 Feb; 82(2):674-81. PubMed ID: 9024275
[TBL] [Abstract][Full Text] [Related]
22. Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia.
Kobayashi K; Imanishi Y; Koshiyama H; Miyauchi A; Wakasa K; Kawata T; Goto H; Ohashi H; Koyano HM; Mochizuki R; Miki T; Inaba M; Nishizawa Y
Life Sci; 2006 Apr; 78(20):2295-301. PubMed ID: 16337659
[TBL] [Abstract][Full Text] [Related]
23. Hypophosphatemia: A Practical Guide to Evaluation and Management.
Tebben PJ
Endocr Pract; 2022 Oct; 28(10):1091-1099. PubMed ID: 35940468
[TBL] [Abstract][Full Text] [Related]
24. X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment.
Kinoshita Y; Fukumoto S
Endocr Rev; 2018 Jun; 39(3):274-291. PubMed ID: 29381780
[TBL] [Abstract][Full Text] [Related]
25. [Clinical aspect of recent progress in phosphate metabolism. Treatment of hypophophatemia].
Minagawa M
Clin Calcium; 2009 Jun; 19(6):852-5. PubMed ID: 19483281
[TBL] [Abstract][Full Text] [Related]
26. [Clinical aspect of recent progress in phosphate metabolism. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23)].
Endo I
Clin Calcium; 2009 Jun; 19(6):815-20. PubMed ID: 19483276
[TBL] [Abstract][Full Text] [Related]
27. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
[TBL] [Abstract][Full Text] [Related]
28. Hypophosphatemic rickets in opsismodysplasia.
Zeger MD; Adkins D; Fordham LA; White KE; Schoenau E; Rauch F; Loechner KJ
J Pediatr Endocrinol Metab; 2007 Jan; 20(1):79-86. PubMed ID: 17315533
[TBL] [Abstract][Full Text] [Related]
29. Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization.
Liu S; Gupta A; Quarles LD
Curr Opin Nephrol Hypertens; 2007 Jul; 16(4):329-35. PubMed ID: 17565275
[TBL] [Abstract][Full Text] [Related]
30. [Chronic bone pain due to raised FGF23 production? The importance of determining phosphate levels].
de Jongh RT; Vervloet MG; Bravenboer N; Heijboer AC; den Heijer M; Lips P
Ned Tijdschr Geneeskd; 2013; 157(28):A5908. PubMed ID: 23841927
[TBL] [Abstract][Full Text] [Related]
31. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice.
Sitara D; Razzaque MS; Hesse M; Yoganathan S; Taguchi T; Erben RG; Jüppner H; Lanske B
Matrix Biol; 2004 Nov; 23(7):421-32. PubMed ID: 15579309
[TBL] [Abstract][Full Text] [Related]
32. FGF23 and Bone and Mineral Metabolism.
Fukumoto S
Handb Exp Pharmacol; 2020; 262():281-308. PubMed ID: 31792685
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic Effects of FGF23 c-tail Fc in a Murine Preclinical Model of X-Linked Hypophosphatemia Via the Selective Modulation of Phosphate Reabsorption.
Johnson K; Levine K; Sergi J; Chamoun J; Roach R; Vekich J; Favis M; Horn M; Cao X; Miller B; Snyder W; Aivazian D; Reagan W; Berryman E; Colangelo J; Markiewicz V; Bagi CM; Brown TP; Coyle A; Mohammadi M; Magram J
J Bone Miner Res; 2017 Oct; 32(10):2062-2073. PubMed ID: 28600887
[TBL] [Abstract][Full Text] [Related]
34. FGF23 and its role in X-linked hypophosphatemia-related morbidity.
Beck-Nielsen SS; Mughal Z; Haffner D; Nilsson O; Levtchenko E; Ariceta G; de Lucas Collantes C; Schnabel D; Jandhyala R; Mäkitie O
Orphanet J Rare Dis; 2019 Feb; 14(1):58. PubMed ID: 30808384
[TBL] [Abstract][Full Text] [Related]
35. Hypophosphatemic rickets/osteomalacia in linear sebaceous nevus syndrome: a variant of tumor-induced osteomalacia.
Carey DE; Drezner MK; Hamdan JA; Mange M; Ahmad MS; Mubarak S; Nyhan WL
J Pediatr; 1986 Dec; 109(6):994-1000. PubMed ID: 3023599
[TBL] [Abstract][Full Text] [Related]
36. FGF23-related hypophosphatemia in patients with low bone mineral density and fragility fractures: challenges in diagnosis and management.
Indirli R; Guabello G; Longhi M; Niada S; Maruca K; Mora S; Maggioni M; Corbetta S
J Endocrinol Invest; 2020 Jun; 43(6):787-798. PubMed ID: 31863362
[TBL] [Abstract][Full Text] [Related]
37. A unique case of adult hypophosphatemic osteomalacia.
Edelson GW; Shih MS; Parfitt AM
Bone; 1993; 14(5):707-10. PubMed ID: 8268043
[TBL] [Abstract][Full Text] [Related]
38. Hypophosphatemic rickets: lessons from disrupted FGF23 control of phosphorus homeostasis.
Goldsweig BK; Carpenter TO
Curr Osteoporos Rep; 2015 Apr; 13(2):88-97. PubMed ID: 25620749
[TBL] [Abstract][Full Text] [Related]
39. Cinacalcet in the management of tumor-induced osteomalacia.
Geller JL; Khosravi A; Kelly MH; Riminucci M; Adams JS; Collins MT
J Bone Miner Res; 2007 Jun; 22(6):931-7. PubMed ID: 17352646
[TBL] [Abstract][Full Text] [Related]
40. Congenital Conditions of Hypophosphatemia in Children.
Imel EA
Calcif Tissue Int; 2021 Jan; 108(1):74-90. PubMed ID: 32328695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
